Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Migraine

Free Subscription Articles published in Neurology Retrieve available abstracts of 75 articles: HTML format

Single Articles

December 2026
1. KUERBITZ JS, Das A, Lyons-Warren AM
   Teaching NeuroImage: Arterial Spin Labeling Demonstrates Cerebral Hemispheric Hypoperfusion in Hemiplegic Migraine.
   Neurology. 2026;107:e218714.
   PubMed    
   
   
   November 2026
2. GANESH A, Galetta SL
   Editors' Note: Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Risk in People With Migraine.
   Neurology. 2026;107:e218780.
   PubMed    
   
   
   
3. SHAHID TANVEER F, Saeed MH
   Reader Response: Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study.
   Neurology. 2026;107:e214870.
   PubMed    
   
   
   
4. WANG K, Lu H
   Reader Response: Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study.
   Neurology. 2026;107:e214903.
   PubMed    
   
   
   
5. PEARSON N, Pasao K, Shadbehr ND
   Reader Response: Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study.
   Neurology. 2026;107:e218038.
   PubMed    
   
   
   
6. MAKITA LM, Katsuyama E, Christensen RH, Takeshima T, et al
   Magnitude and Determinants of Placebo Response in Acute Migraine Trials: A Systematic Review and Meta-Analysis.
   Neurology. 2026;107:e218640.
   PubMed    
   
   
   October 2026
7. BRAMMER KREIBERG MP, Hamann S, Rosenbaum S, Rossing K, et al
   Bridging the Gap: Translating Microemboli-Induced Spreading Depolarization Into Clinical Practice.
   Neurology. 2026;107:e218484.
   PubMed     Abstract available
   
   
   
8. POTREBIC S, Tanveer S, Becker WJ, Burch R, et al
   Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
   Neurology. 2026;107:e214881.
   PubMed     Abstract available
   
   
   
9. PRINGSHEIM T, Smith DB, Tanveer S, Becker WJ, et al
   Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.
   Neurology. 2026;107:e218112.
   PubMed     Abstract available
   
   
   August 2026
10. MAKITA LM, Katsuyama E, Christensen RH, Takeshima T, et al
    Magnitude and Determinants of Placebo Response in Acute Migraine Trials: A Systematic Review and Meta-Analysis.
    Neurology. 2026;107:e218213.
    PubMed     Abstract available
    
    
    July 2026
11. KURTH T, Maassen van den Brink A
    Does Age Matter in Migraine-Stroke Risk?
    Neurology. 2026;107:e214890.
    PubMed    
    
    
    
12. MADSEN TE, Raker CA, Pavlovic JM, Harrington LB, et al
    Migraine and Stroke Risk in Postmenopausal Women in the Women's Health Initiative.
    Neurology. 2026;107:e214825.
    PubMed     Abstract available
    
    
    
13. HILL LJ, Begum G, Thomas CN, Hubbard JC, et al
    Identifying MicroRNA Biomarkers in Idiopathic Intracranial Hypertension: A Pilot Study.
    Neurology. 2026;107:e218162.
    PubMed     Abstract available
    
    
    
14. ROMOZZI M
    Is Migraine a Single Entity?: Machine Learning Reveals Underlying Heterogeneity.
    Neurology. 2026;107:e218177.
    PubMed    
    
    
    
15. DANELAKIS A, Abildsnes HK, Faisal F, Bjork MH, et al
    Machine Diagnostics and Machine Phenotyping of Migraine: A HUNT Study.
    Neurology. 2026;107:e218076.
    PubMed     Abstract available
    
    
    
16. KARLSSON WK, Christensen RH, Al-Khazali HM, Haanes KA, et al
    Plasma CGRP Levels in Migraine: A Registry for Migraine Study.
    Neurology. 2026;107:e218152.
    PubMed     Abstract available
    
    
    June 2026
17. CARONNA E, Mas-de-Les-Valls R, Egeo G, Vazquez MM, et al
    Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
    Neurology. 2026;106:e214945.
    PubMed    
    
    
    
18. CHOU CC, Wu JW, Lin HJ, Wang IJ, et al
    Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.
    Neurology. 2026;106:e218035.
    PubMed     Abstract available
    
    
    May 2026
19. PELES I, Novack L, Gordon M, Sarov B, et al
    Acute Environmental Triggers and Intermediate-Term Modulators of Emergency Migraine-Related Health Care Encounters.
    Neurology. 2026;106:e214936.
    PubMed     Abstract available
    
    
    April 2026
20. JENSEN RH, Lundqvist C, Schytz HW, Tassorelli C, et al
    Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial.
    Neurology. 2026;106:e214863.
    PubMed     Abstract available
    
    
    March 2026
21. MESSINA R, Christensen RH, Ashina H, Sankar A, et al
    Unveiling Resting-State Functional Connectivity Patterns in Patients With Migraine: A REFORM Study.
    Neurology. 2026;106:e214656.
    PubMed     Abstract available
    
    
    February 2026
22. CARONNA E, Mas-de-Les-Valls R, Egeo G, Millan Vazquez M, et al
    Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
    Neurology. 2026;106:e214659.
    PubMed     Abstract available
    
    
    
23. LUSK JB, Wilson LE, Moore C, Yarnell S, et al
    Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study.
    Neurology. 2026;106:e214479.
    PubMed     Abstract available
    
    
    November 2025
24. PENG KP, Mehnert J, May A
    Neuronal Dynamics of Menstrually Related Migraine: A Longitudinal Task-Based fMRI Study.
    Neurology. 2025;105:e214234.
    PubMed     Abstract available
    
    
    
25. COOK JT, Prasad S, Ozudogru S, Ellis CA, et al
    Pearls & Oy-sters: Attacks of Hemiplegic Migraine and Encephalopathy in SLC4A4 Pathogenic Variants.
    Neurology. 2025;105:e214231.
    PubMed     Abstract available
    
    
    
26. TU YH, Huang TC, Tzeng YS, Chen SP, et al
    Prevalence, Clinical Correlates, and Functional Implications of Vestibular Symptoms in Patients With Migraine.
    Neurology. 2025;105:e214248.
    PubMed     Abstract available
    
    
    
27. JANG SI, Kim N, Han K, Lee MJ, et al
    Association Between Obesity and the Risk of Migraine: A Nationwide Cohort Study in South Korea.
    Neurology. 2025;105:e214252.
    PubMed     Abstract available
    
    
    September 2025
28. XUAN Z, Pan Z, Ma C, Lin X, et al
    Reader Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210094.
    PubMed    
    
    
    
29. SCHULZ RS, Rist PM, Kurth T
    Author Response: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e210158.
    PubMed    
    
    
    
30. GANESH A, Galetta SL
    Editors' Note: Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2025;105:e214084.
    PubMed    
    
    
    July 2025
31. ELLER MT, Schwarzova K, Gufler L, Karisik A, et al
    CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review.
    Neurology. 2025;105:e213852.
    PubMed     Abstract available
    
    
    June 2025
32. CAMANNI M, van Gelder MMHJ, Cantarutti A, Nordeng H, et al
    Association of Prenatal Exposure to Triptans, Alone or Combined With Other Migraine Medications, and Neurodevelopmental Outcomes in Offspring.
    Neurology. 2025;104:e213678.
    PubMed     Abstract available
    
    
    March 2025
33. KELLIER D, Anto MM, Hall M, Marin J, et al
    Association of Race and Ethnicity With Emergency Room Rate of Migraine Diagnosis, Testing, and Management in Children With Headache.
    Neurology. 2025;104:e213351.
    PubMed     Abstract available
    
    
    
34. SCHRAMM S, Borner-Schroder C, Reichert M, Ramschutz C, et al
    Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study.
    Neurology. 2025;104:e210235.
    PubMed     Abstract available
    
    
    February 2025
35. HOFFMANN J, Kaube H, Rimmele F, Jurgens TP, et al
    Kinetic Oscillation Stimulation for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Sham-Controlled Trial.
    Neurology. 2025;104:e210220.
    PubMed     Abstract available
    
    
    January 2025
36. LIPTON RB, Gandhi P, Tassorelli C, Reuter U, et al
    Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 Trials.
    Neurology. 2025;104:e210212.
    PubMed     Abstract available
    
    
    
37. LUBOTZKY A, Pai V, Branson HM, Chowdhury SS, et al
    Teaching NeuroImage: Stroke-Like Migraine Attacks After Radiation Therapy Syndrome.
    Neurology. 2025;104:e210203.
    PubMed    
    
    
    December 2024
38. BONNESEN K, Fuglsang CH, Schmidt M
    Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study.
    Neurology. 2024;103:e210034.
    PubMed     Abstract available
    
    
    
39. WANG K, Sico JJ
    Treating Migraine Patients With Cardiovascular Risks: Are NSAIDs the Safer Choice?
    Neurology. 2024;103:e210196.
    PubMed    
    
    
    November 2024
40. 
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209868.
    PubMed    
    
    
    
41. ALLEN C, Rastall DP
    Teaching NeuroImage: Alice in Wonderland Syndrome: Anatomic Correlation.
    Neurology. 2024;103:e209957.
    PubMed    
    
    
    
42. 
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e210022.
    PubMed    
    
    
    September 2024
43. KUMAR A, Joshi D, Singh VK
    Harlequin Syndrome: A Rare Association With Migraine.
    Neurology. 2024;103:e209792.
    PubMed    
    
    
    
44. SCHULZ RS, Glatz T, Buring JE, Rist PM, et al
    Migraine and Risk of Parkinson Disease in Women: A Cohort Study.
    Neurology. 2024;103:e209747.
    PubMed     Abstract available
    
    
    
45. LIPTON RB, Harriott AM, Ma JY, Smith JH, et al
    Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
    Neurology. 2024;103:e209745.
    PubMed     Abstract available
    
    
    August 2024
46. AL-HASSANY L, Acarsoy C, Ikram MK, Bos D, et al
    Sex-Specific Association of Cardiovascular Risk Factors With Migraine: The Population-Based Rotterdam Study.
    Neurology. 2024;103:e209700.
    PubMed     Abstract available
    
    
    July 2024
47. GOADSBY PJ, Friedman DI, Holle-Lee D, Demarquay G, et al
    Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
    Neurology. 2024;103:e209584.
    PubMed     Abstract available
    
    
    May 2024
48. CHRISTENSEN RH, Ashina H, Al-Khazali HM, Zhang Y, et al
    Differences in Cortical Morphology in People With and Without Migraine: A Registry for Migraine (REFORM) MRI Study.
    Neurology. 2024;102:e209305.
    PubMed     Abstract available
    
    
    
49. REUTER U, Goadsby PJ, Ferrari MD, Da Silva Lima GP, et al
    Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
    Neurology. 2024;102:e209349.
    PubMed     Abstract available
    
    
    April 2024
50. DE HAVENON A, Callaghan BC, Xu Y, Connor M, et al
    Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.
    Neurology. 2024;102:e209248.
    PubMed     Abstract available
    
    
    
51. VAN OOSTERHOUT WPJ, Perenboom MJL, Terwindt GM, Ferrari MD, et al
    Frequency and Clinical Features of Space Headache Experienced by Astronauts During Long-Haul Space Flights.
    Neurology. 2024;102:e209224.
    PubMed     Abstract available
    
    
    
52. PETROVA M, Besedina O, Hare B, Gupta A, et al
    Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases. (P9-12.005).
    Neurology. 2024;102.
    PubMed     Abstract available
    
    
    
53. BLUMENFELD A, Mechtler L, Cook L, Rhyne C, et al
    Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001).
    Neurology. 2024;102.
    PubMed     Abstract available
    
    
    February 2024
54. LATEEF TM, Dey D, Leroux A, Cui L, et al
    Association Between Electronic Diary-Rated Sleep, Mood, Energy, and Stress With Incident Headache in a Community-Based Sample.
    Neurology. 2024;102:e208102.
    PubMed     Abstract available
    
    
    
55. PIZER JH, Aita SL, Myers MA, Hawley NA, et al
    Neuropsychological Function in Migraine Headaches: An Expanded Comprehensive Multidomain Meta-Analysis.
    Neurology. 2024;102:e208109.
    PubMed     Abstract available
    
    
    
56. SHAPIRO RE, Nicholson RA, Seng EK, Buse DC, et al
    Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life.
    Neurology. 2024;102:e208074.
    PubMed     Abstract available
    
    
    
57. KEMPNER J
    Brains Under Siege: Assessing the Harmful Effects of Migraine-Related Stigma.
    Neurology. 2024;102:e209192.
    PubMed    
    
    
    January 2024
58. HVITFELDT FUGLSANG C, Pedersen L, Schmidt M, Vandenbroucke JP, et al
    Combined Impact of Migraine and Pregnancy-Induced Hypertension on Long-term Risk of Premature Myocardial Infarction and Stroke.
    Neurology. 2024;102:e207813.
    PubMed     Abstract available
    
    
    November 2023
59. CHIANG CC, Fang X, Horvath Z, Cadiou F, et al
    Simultaneous Comparisons of 25 Acute Migraine Medications Based on 10 Million Users' Self-Reported Records From a Smartphone Application.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000207964.
    PubMed     Abstract available
    
    
    
60. FRIEDMAN SA, Robbins MS
    Millions of Migraine Attacks, Many Answers, More Questions.
    Neurology. 2023 Nov 29:10.1212/WNL.0000000000208084.
    PubMed    
    
    
    August 2023
61. FRIEDMAN BW, Solorzano C, Kessler BD, Martorello K, et al
    Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207648.
    PubMed     Abstract available
    
    
    
62. VANDERPLUYM JH, Victorio MCC, Oakley CB, Rastogi RG, et al
    Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207677.
    PubMed     Abstract available
    
    
    July 2023
63. VANDERPLUYM JH
    Variation in Endpoints in FDA Approvals for Acute and Preventive Migraine Medications: Striving to Compare Apples to Apples.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207672.
    PubMed    
    
    
    
64. SHARPLESS LK, Kesselheim A, Orr SL, Darrow J, et al
    Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207544.
    PubMed     Abstract available
    
    
    
65. PONDER M, Wood ME
    Periconceptional Use of OnabotulinumtoxinA: Need for Comparative Safety Studies.
    Neurology. 2023;101:53-54.
    PubMed    
    
    
    June 2023
66. LIU J, Quan S, Zhao L, Yuan K, et al
    Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments.
    Neurology. 2023 Jun 22:10.1212/WNL.0000000000207484.
    PubMed     Abstract available
    
    
    May 2023
67. ORNELLO R, Sposato LA, Sacco S
    Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1033.
    PubMed    
    
    
    
68. LEWIS A, Galetta S
    Editors' Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032.
    PubMed    
    
    
    
69. SCUTELNIC A, Jung S, Schankin CJ
    Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.
    Neurology. 2023;100:1032-1033.
    PubMed    
    
    
    April 2023
70. KARCESKI S
    Migraine and Hormones: A Complex Interaction.
    Neurology. 2023;100:e1849-e1851.
    PubMed    
    
    
    
71. BARBANTI P, Aurilia C, Egeo G, Torelli P, et al
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine: A Multicenter, Prospective, Observational Study.
    Neurology. 2023 Apr 18:10.1212/WNL.0000000000207292.
    PubMed     Abstract available
    
    
    
72. 
    Efficacy and Safety of Eptinezumab in Patients With Chronic Migraine: PROMISE-2.
    Neurology. 2023 Apr 4:10.1212/WNL.0000000000207168.
    PubMed    
    
    
    March 2023
73. BENKLI B, Kim SY, Koike N, Han C, et al
    Circadian Features of Cluster Headache and Migraine: A Systematic Review, Meta-analysis, and Genetic Analysis.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207240.
    PubMed     Abstract available
    
    
    
74. SUTHERLAND H, Griffiths L
    It's All About the Timing: Circadian Factors in Cluster Headache and Migraine.
    Neurology. 2023 Mar 29:10.1212/WNL.0000000000207329.
    PubMed    
    
    
    August 2022
75. ADDERLEY NJ, Subramanian A, Perrins M, Nirantharakumar K, et al
    Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201064.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum